Clinical Revelance
- Identify clinically relevant mutations in RAS-RAF and PI3K pathways for targeted therapy in a variety of cancers
- Identify and monitor molecular alterations, including those evolving during therapy
- Accelerate development of novel therapeutics through ultra-sensitive detection of clinically relevant mutations